Show simple item record

dc.creatorRaffa, Robert B.
dc.creatorPergolizzi, Joseph V., Jr.
dc.creatorCukier, Herm
dc.date.accessioned2022-09-01T16:19:34Z
dc.date.available2022-09-01T16:19:34Z
dc.date.issued2022-04-29
dc.identifier.citationRaffa, R. , Jr., J. and Cukier, H. (2022) Polysubstance Use and Overdose Visualized via Maps: Opioids. Pharmacology & Pharmacy, 13, 107-118. doi: 10.4236/pp.2022.134008.
dc.identifier.issn2157-9431
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/8120
dc.identifier.urihttp://hdl.handle.net/20.500.12613/8148
dc.description.abstractPolysubstance (combinations of substances) abuse and overdose deaths now surpass mono-substance abuse and overdose deaths. Several international and governmental organizations such as the WHO (World Health Organization), CDC (Centers for Disease Control and Prevention), several of the Institutes of the NIH (National Institutes of Health), Regulators, and Enforcement Agencies, among others, track and provide a valuable source of statistical information about drug (prescription and illicit) (mis)use and overdose. The information is disseminated free to stakeholders and the general public for use. Although the numeric presentations of the data are helpful and adequate for professionals, the non-expert and the visual learner often find visual representation more clear and more compelling. With this in mind, the aim of this study was to present polysubstance use and overdose using visual maps of the available data. This article considers the opioids.
dc.format.extent12 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/ Researcher Works
dc.relation.haspartPharmacology & Pharmacy, Vol. 13, No. 4
dc.relation.isreferencedbyScientific Research Publishing
dc.rightsAttribution CC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectPolysubstance
dc.subjectUse disorder
dc.subjectOverdose
dc.subjectMaps
dc.subjectOpioids
dc.titlePolysubstance Use and Overdose Visualized via Maps: Opioids
dc.typeText
dc.type.genreJournal article
dc.relation.doihttps://doi.org/10.4236/pp.2022.134008
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeTemple University. School of Pharmacy
dc.temple.creatorRaffa, Robert B.
refterms.dateFOA2022-09-01T16:19:34Z


Files in this item

Thumbnail
Name:
Raffa-JournalArticle-2022-04.pdf
Size:
7.089Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY